ARTICLE | Company News
Titan other research news
June 10, 1996 7:00 AM UTC
TTNP's Ingenex Inc. subsidiary received a $750,000 Phase II SBIR grant from the National Institutes of Allergy and Infectious Diseases to develop a genetic approach to treat AIDS. The grant will fund...